Pimavanserin Tartrate
Who holds supplier records for Pimavanserin Tartrate? 6 organisations hold a current record for Pimavanserin Tartrate: an active US FDA Type II Drug Master File. A further 1 organisation has only historical (inactive) DMF filings. Recorded organisation countries for current records: India (4), China (1) and Poland (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records
Cite as: PharmaTek, “Pimavanserin Tartrate: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/pimavanserin-tartrate
Reading the evidence
- 6 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
4 of the 6 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 4 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (6)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Pimavanserin Tartrate. Country is the organisation's recorded country, not necessarily the manufacturing site.
- BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITEDIndiaActive DMF 34415 · latest filing Dec 2019
- DASAMI LAB PRIVATE LTDIndia Company GMP cert on recordActive DMF 34354 · latest filing Feb 2020
- JIANGSU TASLY DIYI PHARMACEUTICAL CO LTDChinaActive DMF 37430 · latest filing Dec 2022
- MSN LIFE SCIENCES PRIVATE LIMITEDIndia Company GMP cert on recordActive DMF 33292 · latest filing Oct 2018
- Zakłady Farmaceutyczne Polpharma S.A.Poland Company GMP cert on recordActive DMF 33385 · latest filing Dec 2018
- Zydus Lifesciences LimitedIndia Company GMP cert on recordActive DMF 35029 · latest filing Jul 2020
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (1)
Organisations whose Type II DMFs for Pimavanserin Tartrate are no longer active. These show a past filing, not current supply.
Show all 1 historical record
- China · Inactive DMF 34289 · filed Dec 2019
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Pimavanserin Tartrate is an atypical antipsychotic that targets the serotonergic system and is used primarily for the treatment of Parkinson's disease psychosis. It functions by selectively antagonizing serotonin receptors and is notable for not influencing dopaminergic receptors.
Chemical identity
- IUPAC name
- (2R,3R)-2,3-dihydroxybutanedioic acid;bis(1-[(4-fluorophenyl)methyl]-1-(1-methylpiperidin-4-yl)-3-[[4-(2-methylpropoxy)phenyl]methyl]urea)
- Canonical SMILES
- CC(C)COC1=CC=C(C=C1)CNC(=O)N(CC2=CC=C(C=C2)F)C3CCN(CC3)C.CC(C)COC1=CC=C(C=C1)CNC(=O)N(CC2=CC=C(C=C2)F)C3CCN(CC3)C.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O
- InChIKey
- RGSULKHNAKTFIZ-CEAXSRTFSA-N
- Synonyms
- Nuplazid API, acp-103, nuplazid
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Atypical Antipsychotic
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Pimavanserin Tartrate?
6 organisations hold an active US FDA Type II Drug Master File or a CEP for Pimavanserin Tartrate: BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (India), DASAMI LAB PRIVATE LTD (India), JIANGSU TASLY DIYI PHARMACEUTICAL CO LTD (China), MSN LIFE SCIENCES PRIVATE LIMITED (India), Zakłady Farmaceutyczne Polpharma S.A. (Poland) and Zydus Lifesciences Limited (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Pimavanserin Tartrate Drug Master Files are active?
BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (DMF 34415), DASAMI LAB PRIVATE LTD (DMF 34354), JIANGSU TASLY DIYI PHARMACEUTICAL CO LTD (DMF 37430), MSN LIFE SCIENCES PRIVATE LIMITED (DMF 33292), Zakłady Farmaceutyczne Polpharma S.A. (DMF 33385) and Zydus Lifesciences Limited (DMF 35029). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Pimavanserin Tartrate records mean?
1 organisation has only inactive Type II DMFs for Pimavanserin Tartrate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Pimavanserin Tartrate supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Pimavanserin Tartrate?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.